R&D/ Views & Analysis/ Views and analysis Q&A: Albireo’s Ron Cooper on bile acid modulation George Underwood Albireo, bile acid 0 Comment While bile acids might not be as trendy as gene editing, modulating them has potential for first-in-class therapies Share X Q&A: Albireo’s Ron Cooper on bile acid modulation https://pharmaphorum.com/r-d/views-analysis-r-d/qa-albireos-ron-cooper-on-bile-acid-modulation/
